Dr. DeSelm is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Dept Oncology
Saint Louis, MO 63110Phone+1 314-747-7236Fax+1 314-362-8099
Summary
Education & Training
Memorial Sloan Kettering Cancer CenterTranslational Research, 2017 - 2018- Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2013 - 2017
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 2012 - 2013- Washington University in St. Louis School of MedicineClass of 2012
Certifications & Licensure
IL State Medical License 2020 - 2026
MO State Medical License 2018 - 2025
NY State Medical License 2013 - 2019- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Agilent 2020 Early Career Professor Award Agilent, 2020
- Early Independence Award (DP5) NIH
Publications & Presentations
PubMed
- 243 citationsDendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer.Samarth Hegde, Varintra E. Krisnawan, Brett H. Herzog, Chong Zuo, Marcus A. Breden
Cancer Cell. 2020-03-16 - 84 citationsCARD8 is an inflammasome sensor for HIV-1 protease activity.Qiankun Wang, Hongbo Gao, Kolin M. Clark, Christian Shema Mugisha, Keanu Davis
Science. 2021-02-04 - 3 citationsInitial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program.Alex T Price, Joshua P Schiff, Eric Laugeman, Borna Maraghechi, Matthew Schmidt
Clinical and Translational Radiation Oncology. 2023-09-01
Abstracts/Posters
- MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T TherapyCarl DeSelm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...Carl DeSelm, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Telluride Alum Receives Prestigious HonorOctober 23rd, 2020
Grant Support
- The Role Of Paxillin In The OsteoclastNational Institute On Aging2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
